21st May 2022 | Pharma Updates
Drug pricing watchdogs focusing on large profit margins
The National Pharmaceutical Pricing Authority (NPPA), which regulates drug prices, has launched an initiative to limit the huge margins that can reach 1,000% in some cases, raising the MRP for patients.
USFDA approved Glenmark Pharmaceuticals Abiraterone Acetate Tablets
US FDA has given final approval to Glenmark Pharmaceuticals’ Abiraterone Acetate Tablets USP, 500 mg, a generic version of Janssen Biotech Inc. ‘s Zytiga®1 Tablets, 500 mg.
Biocon benefits 4% as its cancer treatment product Abevmy is launched
Biocon Biologics and Viatris launched a biosimilar product called Abevmy (bBevacizumab) in Canada for use in cancer treatment, which sent the stock up 3.6 percent in early trading Friday.
Centrient Pharma achieved 100% PNEC compliance in manufacturing of oral antibiotics
The Punjab Pollution Control Board (PPCB) fined a pharmaceutical company based in Dera Bassi 5 lakh for multiple violations of the Water (Prevention and Control of Pollution) Act.
Top pharmaceutical companies' profits in Bangladesh are declining
Pharmaceutical profit growth in Bangladesh slowed in the first quarter of this fiscal year compared to the same period last year, owing to higher operating costs despite higher sales.
Sanofi's Dupixent, first FDA-approved treatment for eosinophilic esophagitis
Dupixent, a joint venture between Sanofi and Regeneron, has just received a new FDA indication as the first and only medicine approved to treat eosinophilic esophagitis (EoE).
Siga receives requests for smallpox drugs in Europe
As cases of monkeypox spread across Europe, Siga Technologies’s executive officer told that the company has received requests to use its smallpox drug to treat them.
